Semaglutide, sold under the brand names Wegovy and Ozempic, has helped Novo establish a foothold in the market for ...

Weight-loss giant Novo Nordisk's shares rose over 5% on Friday ​to a high last touched in October, ‌driven by "encouraging" ...

Focusing on Novo Nordisk, Aimee Donnellan’s book ranges across R&D, patents, medical effects and the stigma attached to ...

The U.K.’s health regulator approved a higher dose of Novo Nordisk’s Wegovy weight-loss drug applicable to patients with a ...

Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

Shares in Denmark's global healthcare company, Novo Nordisk jumped sharply on Friday after the U.K.'s regulator signed off on ...

Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than ...

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo ...

Pharma giant Novo Nordisk A/S (NYSE:NVO) created quite the buzz last month after its weight loss pill secured approval from ...